TNPSC Thervupettagam

Clostridioides difficile Vaccine

November 1 , 2024 28 days 129 0
  • Researchers are developed the first successful mRNA vaccine against the highly contagious and difficult-to-treat Clostridioides difficile bacteria.
  • C. difficile causes an infection of the colon, the longest part of the large intestine.
  • The infection often occurs after antibiotic use and mainly affects older adults in hospitals or long-term care settings.
  • Roughly one-third of infected individuals will have recurrent infections.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories